Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Binder, BR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 175 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ruan, QR; Zhang, WJ; Hufnagl, P; Kaun, C; Binder, BR; Wojta, J
      Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: Contribution of the NF-kappa B pathway

      JOURNAL OF VASCULAR RESEARCH
    2. de Maat, MPM; Dooijewaard, G; Meijer, P; Binder, BR; Keber, D; Risberg, B; Kluft, C; Jespersen, J
      Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Redondo, M; Carroll, VA; Mauron, T; Biasiutti, FD; Binder, BR; Lammle, B; Wuillemin, WA
      Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events

      BLOOD COAGULATION & FIBRINOLYSIS
    4. Vrtala, S; Hirtenlehner, K; Susani, M; Akdis, M; Kussebi, F; Akdis, CA; Blaser, K; Hufnagl, P; Binder, BR; Politou, A; Pastore, A; Vangelista, L; Sperr, WR; Semper, H; Valent, P; Ebner, C; Kraft, D; Valenta, R
      Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1

      FASEB JOURNAL
    5. Leitinger, N; Huber, J; Rizza, C; Mechtcheriakova, D; Bochkov, V; Koshelnick, Y; Berliner, JA; Binder, BR
      The isoprostane 8-iso-PGF(2 alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation

      FASEB JOURNAL
    6. Mechtcheriakova, D; Schabbauer, G; Lucerna, M; Clauss, M; De Martin, R; Binder, BR; Hofer, E
      Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells

      FASEB JOURNAL
    7. Christ, G; Graf, S; Huber-Beckmann, R; Zorn, G; Lang, I; Kneussl, M; Binder, BR; Huber, K
      Impairment of the plasmin activation system in primary pulmonary hypertension: Evidence for gender differences

      THROMBOSIS AND HAEMOSTASIS
    8. Plas, E; Carroll, VA; Jilch, R; Simak, R; Mihaly, J; Melchior, S; Thuroff, JW; Binder, BR; Pfluger, H
      Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer

      CYTOMETRY
    9. Korschineck, I; Ziegler, S; Breuss, J; Lang, I; Lorenz, M; Kaun, C; Ambros, PF; Binder, BR
      Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Jerabek, I; Zechmeister-Machhart, M; Binder, BR; Geiger, M
      Binding of retinoic acid by the inhibitory serpin protein C inhibitor

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    11. Oitzinger, W; Hofer-Warbinek, R; Schmid, JA; Koshelnick, Y; Binder, BR; de Martin, R
      Adenovirus-mediated expression of a mutant I kappa B kinase 2 inhibits theresponse of endothelial cells to inflammatory stimuli

      BLOOD
    12. Carroll, VA; Mihaly, J; Koshelnick, Y; Hufnagl, P; Binder, BR
      Overexpression of plasminogen activator inhibitor type-1 in HT-1080 fibrosarcoma cells promotes lung colonisation and in vitro cell adhesion

      FIBRINOLYSIS & PROTEOLYSIS
    13. Sperr, WR; Natter, S; Baghestanian, M; Smolen, J; Wolff, K; Binder, BR; Muller, MR; Lechner, K; Valenta, R; Valent, P
      Autoantibody reactivity in a case of Schnitzler's syndrome: Evidence for aTh1-like response and detection of IgG2 anti-Fc epsilon RIa antibodies

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    14. Roller, RE; Janisch, S; Kvas, E; Schnedl, WJ; Binder, BR; Wojta, J; Korninger, C
      Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty

      THROMBOSIS AND HAEMOSTASIS
    15. Uhrin, P; Dewerchin, M; Hilpert, M; Chrenek, P; Schofer, C; Zechmeister-Machhart, M; Kronke, G; Vales, A; Carmeliet, P; Binder, BR; Geiger, M
      Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility

      JOURNAL OF CLINICAL INVESTIGATION
    16. Hofer-Warbinek, R; Schmid, JA; Stehlik, C; Binder, BR; Lipp, J; de Martin, R
      Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Schmid, JA; Birbach, A; Hofer-Warbinek, R; Pengg, M; Burner, U; Furtmuller, PG; Binder, BR; de Martin, R
      Dynamics of NF kappa B and I kappa B alpha studied with green fluorescent protein (GFP) fusion proteins - Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer

      JOURNAL OF BIOLOGICAL CHEMISTRY
    18. Prendes, MJ; Binder, BR; Geiger, M
      Response: Protein C inhibitor does exist in platelets

      BLOOD
    19. Turecek, PL; Schwarz, HP; Binder, BR
      In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor

      BLOOD
    20. Holzmuller, H; Moll, T; Hofer-Warbinek, R; Mechtcheriakova, D; Binder, BR; Hofer, E
      A transcriptional repressor of the tissue factor gene in endothelial cells

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    21. Mavri, A; Stegnar, M; Krebs, M; Sentocnik, JT; Geiger, M; Binder, BR
      Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    22. Redondo, M; Watzke, HH; Stucki, B; Sulzer, I; Biasiutti, FD; Binder, BR; Furlan, M; Lammle, B; Wuillemin, WA
      Coagulation factors II, V, VII, and X, prothrombin gene 20210G -> A transition, and factor V Leiden in coronary artery disease - High factor V clotting activity is an independent risk factor for myocardial infarction

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    23. Seiberler, S; Bugajska-Schretter, A; Hufnagl, P; Binder, BR; Stockl, J; Spitzauer, S; Valent, P; Valenta, R
      Characterization of IgE-reactive autoantigens in atopic dermatitis - 1. Subcellular distribution and tissue-specific expression

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    24. Seiberler, S; Natter, S; Hufnagl, P; Binder, BR; Valenta, R
      Characterization of IgE-reactive autoantigens in atopic dermatitis - 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    25. Vrtala, S; Hirtenlehner, K; Susani, M; Hufnagl, P; Binder, BR; Vangelista, L; Pastore, A; Sperr, WR; Valent, P; Ebner, C; Kraft, D; Valenta, R
      Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    26. Zhang, JC; Ruan, QR; Paucz, L; Fabry, A; Binder, BR; Wojta, J
      Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro

      JOURNAL OF VASCULAR RESEARCH
    27. Bavinzski, G; Richling, B; Binder, BR; Gruber, A; Talazoglu, V; Dietrich, W; Schwendtenwein, I; Plenk, H
      Histopathological findings in experimental aneurysms embolized with conventional and thrombogenic/antithrombolytic Guglielmi coils

      MINIMALLY INVASIVE NEUROSURGERY
    28. Christ, G; Kostner, K; Zehetgruber, M; Binder, BR; Gulba, D; Huber, K
      Plasmin activation system in restenosis: Role in pathogenesis and clinicalprediction?

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    29. Wimazal, F; Sperr, WR; Horny, HP; Carroll, V; Binder, BR; Fonatsch, C; Walchshofer, S; Fodinger, M; Schwarzinger, I; Samorapoompichit, P; Chott, A; Dvorak, AM; Lechner, K; Valent, P
      Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells

      AMERICAN JOURNAL OF HEMATOLOGY
    30. Krebs, M; Kaun, C; Lorenz, M; Haag-Weber, M; Geiger, M; Binder, BR
      Protease dependent activation of endothelial cells by peritoneal dialysis effluents

      THROMBOSIS AND HAEMOSTASIS
    31. Koshelnick, Y; Ehart, M; Stockinger, H; Binder, BR
      Mechanisms of signaling through urokinase receptor and the cellular response

      THROMBOSIS AND HAEMOSTASIS
    32. Gottsauner-Wolf, M; Sochor, H; Hornykewycz, S; Beckmann, R; Long, I; Probst, P; Binder, BR; Huber, K
      Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients

      THROMBOSIS AND HAEMOSTASIS
    33. Finsterer, J; Gharehbaghi-Schnell, E; Korschineck, I; Fheodoroff, K; Seiser, A; Loscher, W; Binder, BR; Mamoli, B
      Phenotype and CTG-repeat size in myotonic dystrophy: A study of 26 patients and 55 relatives

      JOURNAL OF NEUROGENETICS
    34. Ebel, T; Gerhards, J; Binder, BR; Lipp, J
      Theileria parva 104 kDa microneme-rhoptry protein is membrane-anchored by a non-cleaved amino-terminal signal sequence for entry into the endoplasmicreticulum

      MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    35. Carroll, VA; Binder, BR
      The role of the plasminogen activation system in cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    36. Roller, RE; Janisch, S; Carroll, V; Kvas, E; Pilger, E; Binder, BR; Wojta, J
      Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty

      THROMBOSIS RESEARCH
    37. Binder, BR
      Untitled

      WIENER KLINISCHE WOCHENSCHRIFT
    38. Zoellner, H; Hou, JY; Lovery, M; Kingham, J; Srivastava, M; Bielek, E; Vanyek, E; Binder, BR
      Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin

      MICROVASCULAR RESEARCH
    39. Wojta, J; Kaun, C; Breuss, JM; Koshelnick, Y; Beckmann, R; Hattey, E; Mildner, M; Weninger, W; Nakamura, T; Tschachler, E; Binder, BR
      Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells

      LABORATORY INVESTIGATION
    40. Krebs, M; Uhrin, P; Vales, A; Prendes-Garcia, MJ; Wojta, J; Geiger, M; Binder, BR
      Protein C inhibitor is expressed in keratinocytes of human skin

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    41. Sillalber, C; Baghestanian, M; Bevec, D; Willheim, M; Agis, H; Kapiotis, S; Fureder, W; Bankl, HC; Kiener, HP; Speiser, W; Binder, BR; Lechner, K; Valent, P
      The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis

      JOURNAL OF IMMUNOLOGY
    42. Godar, S; Horejsi, V; Weidle, UH; Binder, BR; Hansmann, C; Stockinger, H
      M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta 1

      EUROPEAN JOURNAL OF IMMUNOLOGY
    43. Prendes, MJ; Bielek, E; Zechmeister-Machhart, M; Vanyek-Zavadil, E; Carroll, VA; Breuss, J; Binder, BR; Geiger, M
      Synthesis and ultrastructural localization of protein C inhibitor in humanplatelets and megakaryocytes

      BLOOD
    44. Mechtcheriakova, D; Wlachos, A; Holzmuller, H; Binder, BR; Hofer, E
      Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1

      BLOOD
    45. EHART M; KOSHELNICK Y; STOCKINGER H; BINDER BR
      INTERACTIONS OF UPAR - IMPACT ON RECEPTOR REGULATION AND SIGNAL-TRANSDUCTION

      FIBRINOLYSIS & PROTEOLYSIS
    46. GEPPERT A; GRAF S; BECKMANN R; HORNYKEWYCZ S; SCHUSTER E; BINDER BR; HUBER K
      CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE

      Arteriosclerosis, thrombosis, and vascular biology
    47. VALENT P; SILLABER C; BAGHESTANIAN M; BANKL HC; KIENER HP; LECHNER K; BINDER BR
      WHAT HAVE MAST-CELLS TO DO WITH EDEMA FORMATION, THE CONSECUTIVE REPAIR AND FIBRINOLYSIS

      International archives of allergy and immunology
    48. CARROLL V; KOSHELNICK Y; PODESVA K; MATSUDA E; HUFNAGL P; BINDER BR
      EXPRESSION OF PAI-1 IN 2 HT1080 CELL-LINES - POSITIVE CORRELATION WITH FORMATION OF LUNG METASTASES BUT NEGATIVE WITH PRIMARY TUMOR-FORMATION

      The FASEB journal
    49. KREBS M; KAUN C; LORENZ M; HAAGWEBER M; VALENT P; GEIGER M; BINDER BR
      ENDOTHELIAL ACTIVATION BY A PROTEASE PRESENT IN PERITONEAL-DIALYSIS EFFLUENTS (PDES) FROM PATIENTS WITH RENAL-FAILURE

      The FASEB journal
    50. BREUSS JM; VALES A; HATTEY E; ZHEGU Z; KAUN C; NAKAMURA T; BINDER BR; WOJTA J
      HGF REGULATES VEGF RECEPTOR EXPRESSION IN VASCULAR ENDOTHELIAL AND SMOOTH-MUSCLE CELLS

      The FASEB journal
    51. NATTER S; SEIBERLER S; HUFNAGL P; BINDER BR; HIRSCHL AM; RING J; ABECK D; SCHMIDT T; VALENT P; VALENTA R
      ISOLATION OF CDNA CLONES CODING FOR IGE AUTOANTIGENS WITH SERUM IGE FROM ATOPIC-DERMATITIS PATIENTS

      The FASEB journal
    52. Ambros, PF; Schmid, J; Rumpler, S; Binder, BR; de Martin, R
      Localization of the human I-kappa B kinase-beta (IKBKB) to chromosome 8p11.2 by fluorescence in situ hybridization and radiation hybrid mapping

      GENOMICS
    53. HUBER H; ZOJER N; BINDER BR
      BIOMEDICAL-RESEARCH IN AUSTRIA - ONCOLOGY AS EXAMPLE

      Onkologie
    54. STEGNAR M; UHRIN P; PETERNEL P; MAVRI A; SALOBIRPAJNIC B; STARE J; BINDER BR
      THE 4G 5G SEQUENCE POLYMORPHISM IN THE PROMOTER OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE - RELATIONSHIP TO PLASMA PAI-1 LEVEL IN VENOUS THROMBOEMBOLISM/

      Thrombosis and haemostasis
    55. ZEHETGRUBER M; CHRIST G; GABRIEL H; MUNDIGLER G; BECKMANN R; BINDER BR; HUBER K
      EFFECT OF ANTIHYPERTENSIVE TREATMENT WITH DOXAZOSIN ON INSULIN SENSITIVITY AND FIBRINOLYTIC PARAMETERS

      Thrombosis and haemostasis
    56. GHAREHBAGHISCHNELL E; FINSTERER J; KORSCHINECK I; MAMOLI B; BINDER BR
      MYOTONIC-DYSTROPHY - MOLECULAR-GENETICS AND DIAGNOSIS

      Wiener Klinische Wochenschrift
    57. STEHLIK C; DEMARTIN R; KUMABASHIRI I; SCHMID JA; BINDER BR; LIPP J
      NUCLEAR FACTOR (NF)-KAPPA-B-REGULATED X-CHROMOSOME-LINKED IAP GENE-EXPRESSION PROTECTS ENDOTHELIAL-CELLS FROM TUMOR-NECROSIS-FACTOR ALPHA-INDUCED APOPTOSIS

      The Journal of experimental medicine
    58. PLAS E; CARROLL VA; JILCH R; MIHALY J; VESELY M; ULRICH W; PFLUGER H; BINDER BR
      ANALYSIS OF FIBRINOLYTIC PROTEINS IN RELATION TO DNA-PLOIDY IN PROSTATE-CANCER

      International journal of cancer
    59. GHAREHBAGHISCHNELL EB; FINSTERER J; KORSCHINECK I; MAMOLI B; BINDER BR
      GENOTYPE-PHENOTYPE CORRELATION IN MYOTONIC-DYSTROPHY

      Clinical genetics
    60. HUBER K; GRIFFITHS M; BREITENWIESER A; SCHOCHER I; SARA M; SLEYTR UB; ZASMETA G; BECKMANN R; ZEINER A; SCHREIBER G; BINDER BR
      COMPARISON OF A NEW RAPID BEDSIDE ASSAY FOR T-PA WITH A COMMERCIALLY AVAILABLE ELISA - POSSIBLE IMPORTANCE OF T-PA ANTIGEN DETERMINATION DURING THROMBOLYTIC THERAPY FOR PREDICTION OF OUTCOME

      Circulation
    61. STEHLIK C; DEMARTIN R; BINDER BR; LIPP J
      CYTOKINE-INDUCED EXPRESSION OF PORCINE INHIBITOR OF APOPTOSIS PROTEIN(IAP) FAMILY MEMBER IS REGULATED BY NF-KAPPA-B

      Biochemical and biophysical research communications
    62. STEGNAR M; PETERNEL P; UHRIN P; CVELBARMARINKO T; GORSICTOMAZIC K; BINDER BR
      FIBRINOLYSIS IN PATIENTS WITH THE 1691-G-]A MUTATION IN FACTOR-V GENEAND HISTORY OF DEEP-VEIN THROMBOSIS

      Fibrinolysis & proteolysis
    63. ZEHETGRUBER M; BECKMANN R; GABRIEL H; CHRIST G; BINDER BR; HUBER K
      COMPARATIVE CROSS-OVER STUDY OF THE EFFECTS OF LISINOPRIL AND DOXAZOSIN ON INSULIN, GLUCOSE AND LIPOPROTEIN METABOLISM AND THE ENDOGENOUS FIBRINOLYTIC SYSTEM

      Fibrinolysis & proteolysis
    64. ZHANG WJ; BAMMER T; BINDER BR; WOJTA J
      EFFECT OF ENDOTHELIN ON THE REGULATION OF THE FIBRINOLYTIC SYSTEM OF CULTURED HUMAN VASCULAR SMOOTH-MUSCLE CELLS

      FIBRINOLYSIS & PROTEOLYSIS
    65. CHRIST G; HUFNAGL P; KAUN C; MUNDIGLER G; LAUFER G; HUBER K; WOJTA J; BINDER BR
      ANTIFIBRINOLYTIC PROPERTIES OF THE VASCULAR WALL - DEPENDENCE ON THE HISTORY OF SMOOTH-MUSCLE CELL DOUBLINGS IN-VITRO AND IN-VIVO

      Arteriosclerosis, thrombosis, and vascular biology
    66. ZHANG WJ; WOJTA J; BINDER BR
      NOTOGINSENOSIDE R1 COUNTERACTS ENDOTOXIN-INDUCED ACTIVATION OF ENDOTHELIAL-CELLS IN-VITRO AND ENDOTOXIN-INDUCED LETHALITY IN MICE IN-VIVO

      Arteriosclerosis, thrombosis, and vascular biology
    67. CARROLL VA; GRIFFITHS MR; GEIGER M; MERLO C; FURLAN M; LAMMLE B; BINDER BR
      PLASMA-PROTEIN-C INHIBITOR IS ELEVATED IN SURVIVORS OF MYOCARDIAL-INFARCTION

      Arteriosclerosis, thrombosis, and vascular biology
    68. ZHANG WJ; WOJTA J; BINDER BR
      REGULATION OF THE FIBRINOLYTIC POTENTIAL OF CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - ASTRAGALOSIDE-IV DOWN-REGULATES PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND UP-REGULATES TISSUE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION

      Journal of vascular research
    69. DEMARTIN R; RAIDL M; HOFER E; BINDER BR
      ADENOVIRUS-MEDIATED EXPRESSION OF GREEN FLUORESCENT PROTEIN

      Gene therapy
    70. ZECHMEISTERMACHHART M; HUFNAGL P; UHRIN P; KORSCHINECK I; BINDER BR; GEIGER M
      MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF THE MOUSE PROTEIN-C INHIBITOR GENE

      Gene
    71. BAGHESTANIAN M; HOFBAUER R; KRESS HG; WOJTA J; FABRY A; BINDER BR; KAUN C; MULLER MR; MEHRABI MR; KAPIOTIS S; SENGOELGE G; GHANNADAN M; LECHNER K; VALENT P
      THROMBIN AUGMENTS VASCULAR CELL-DEPENDENT MIGRATION OF HUMAN MAST-CELLS - ROLE OF MGF

      Thrombosis and haemostasis
    72. STEGNAR M; UHRIN P; PETERNEL P; MAVRI A; ZEYDA M; SALOBIRPAJNIC B; BINDER BR
      ASSOCIATION OF THE 4G 5G POLYMORPHISM AND METABOLIC FACTORS TO PLASMAPLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN DEEP-VEIN THROMBOSIS/

      Thrombosis and haemostasis
    73. CARROLL VA; HUFNAGL P; MATSUDA E; BINDER BR
      PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) OVEREXPRESSION IN HUMAN FIBROSARCOMA CELL INDUCES EXPERIMENTAL METASTASES IN ATHYMIC MICE

      Thrombosis and haemostasis
    74. BREUSS JM; ERLE DJ; PYTELA R; KAUN C; NAKAMURA T; BINDER BR; WOJTA J
      TNF AND HGF INDUCE UP-REGULATION OF THE ALPHA-4-BETA-7 INTEGRIN EXPRESSED ON CULTURED ENDOTHELIAL-CELLS

      Thrombosis and haemostasis
    75. STEGNAR M; PETERNEL P; UHRIN P; CVELBARMARINKO T; GORSICTOMAZIC K; BINDER BR
      THE 1691-G-]A MUTATION IN FACTOR-V GENE AND IMPAIRED FIBRINOLYSIS IN PATIENTS WITH HISTORY OF DEEP-VEIN THROMBOSIS

      Thrombosis and haemostasis
    76. KORSCHINECK I; LANG I; GHAREHBAGHISCHNELL E; ZIEGLER S; KAUN C; AMBROS P; BINDER BR
      IDENTIFICATION OF NOVEL ALTERNATIVELY SPLICED APOLIPOPROTEIN-E RECEPTOR 2 MESSENGER-RNAS WITH ALTERED LIGAND-BINDING SITES

      Thrombosis and haemostasis
    77. KREBS M; GEIGER M; BINDER BR
      INTERACTION OF HEPARIN-COFACTOR-II (HCII) AND COMPLEMENT FACTOR-D (ADIPSIN)

      Thrombosis and haemostasis
    78. ZASMETA G; ZEINER A; HORNYKEWYCZ S; BECKMANN R; ZORN G; DOMANOVITS H; SCHREIBER W; LAGGNER AN; BINDER BR; HUBER K
      BIOCHEMICAL MONITORING OF DOUBLE-BOLUS VERSUS FRONT-LOADED THROMBOLYTIC THERAPY WITH ALTEPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    79. UCHIBA M; OKAJIMA K; MURAKAMI K; WOJTA J; KAUN C; BINDER BR
      ATTENUATION OF ENDOTOXIN-INDUCED PULMONARY VASCULAR INJURY BY ANTITHROMBIN-III

      Thrombosis and haemostasis
    80. ROLLER RE; HUBER A; BECKMANN R; WOJTA J; HUBER JC; BINDER BR
      FIBRINOLYTIC SYSTEM IN NON MALIGNANT HUMAN OVARY CYSTS IN FERTILE WOMEN

      Thrombosis and haemostasis
    81. ZHANG WJ; HUFNAGL P; WOJTA J; BINDER BR
      EFFECT OF ASTRAGALOSIDE-IV ON INHIBITING ENDOTOXIN AND TNF-ALPHA STIMULATED INDUCTION OF CELL-ADHESION MOLECULES IN POLYMORPHONUCLEAR (PMN)LEUKOCYTES AND PMN LEUKOCYTE ADHESION TO CULTURED HUMAN ENDOTHELIAL-CELLS

      Thrombosis and haemostasis
    82. ZHANG WJ; HUFNAGL P; WOJTA J; BINDER BR
      MECHANISM OF THE ACTION OF ASTRAGALOSIDE-IV - INHIBITION OF ENDOTOXINEFFECTS THROUGH INDUCTION OF IKB-ALPHA SYNTHESIS

      Thrombosis and haemostasis
    83. HOFER E; HOLZMULLER H; HOFERWARBINEK R; MECHTCHERIAKOVA D; LUCERNA M; KRONNERWETTER W; HUFNAGL P; BINDER BR
      PROMOTER ANALYSIS OF THE GENES FOR TISSUE FACTOR (TF) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-I)

      Thrombosis and haemostasis
    84. TSUCHIYA H; SUNAYAMA C; OKADA G; MATSUDA E; TOMITA K; BINDER BR
      PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACCELERATES LUNG METASTASIS FORMATION OF HUMAN FIBROSARCOMA CELLS

      Anticancer research
    85. GEIGER M; KREBS M; JERABEK I; BINDER BR
      PROTEIN-C INHIBITOR (PCI) AND HEPARIN-COFACTOR-II (HCII) - POSSIBLE ALTERNATIVE ROLES OF THESE HEPARIN-BINDING SERPINS OUTSIDE THE HEMOSTATIC SYSTEM

      Immunopharmacology
    86. ZHANG WJ; WOJTA J; BINDER BR
      EFFECT OF NOTOGINSENOSIDE R1 ON THE SYNTHESIS OF COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN CULTURED SMOOTH-MUSCLE CELLS OF HUMAN PULMONARY-ARTERY

      Cellular and molecular biology
    87. NATTER S; SEIBERLER S; HUFNAGL P; BINDER BR; RING J; ABECK D; SCHMIDT T; VALENT P; VALENTA R
      IGE-AUTOANTIBODIES FROM ATOPIC-DERMATITIS PATIENTS SPECIFICALLY RECOGNIZE CDNA CLONES CODING FOR HUMAN

      Journal of investigative dermatology
    88. KOSHELNICK Y; EHART M; HUFNAGL P; HEINRICH PC; BINDER BR
      UROKINASE RECEPTOR IS ASSOCIATED WITH THE COMPONENTS OF THE JAK1 STAT1 SIGNALING PATHWAY AND LEADS TO ACTIVATION OF THIS PATHWAY UPON RECEPTOR CLUSTERING IN THE HUMAN KIDNEY EPITHELIAL TUMOR-CELL LINE TCL-598/

      The Journal of biological chemistry
    89. SILLABER C; BAGHESTANIAN M; HOFBAUER R; VIRGOLINI I; BANKL HC; FUREDER W; AGIS H; WILLHEIM M; LEIMER M; SCHEINER O; BINDER BR; KIENER HP; BEVEC D; FRITSCH G; MAJDIC O; KRESS HG; GADNER H; LECHNER K; VALENT P
      MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF THE UROKINASE RECEPTOR ON HUMAN MAST-CELLS

      The Journal of biological chemistry
    90. ECKE S; GEIGER M; BINDER BR
      HEPARIN-BINDING OF PROTEIN-C INHIBITOR - ANALYSIS OF THE EFFECT OF HEPARIN ON THE INTERACTION OF PROTEIN-C INHIBITOR WITH TISSUE KALLIKREIN

      European journal of biochemistry
    91. KAUN C; BREUSS JM; BECKMANN R; HATTEY E; MILDNER M; TSCHACHLER E; NAKAMURA T; BINDER BR; WOJTA J
      HEPATOCYTE GROWTH-FACTOR (HGF) STIMULATES PRODUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IN HUMAN KERATINOCYTES AND FLK-1 IN HUMAN ENDOTHELIAL-CELLS IN-VITRO

      Blood
    92. KREBS M; HAAGWEBER M; LORENZ M; GEIGER M; BINDER BR
      INDUCTION OF TISSUE FACTOR EXPRESSION IN ENDOTHELIAL-CELLS BY A PROTEASE PRESENT IN THE PERITONEAL-DIALYSIS EFFLUENT (PDE) FROM PATIENTS WITH RENAL-FAILURE

      Blood
    93. CARROLL V; KOSHELNICK Y; PODESVA K; MATSUDA E; HUFNAGL P; BINDER BR
      OVEREXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN 2 DISTINCT HUMAN FIBROSARCOMA CELL-LINES - POSITIVE CORRELATION WITH THE FORMATION OF LUNG METASTASES BUT NEGATIVE WITH PRIMARY TUMOR-FORMATION

      Blood
    94. DEMARTIN R; STEHLIK C; KUMABASHIRI I; BINDER BR; LIPP J
      NF-KB-DEPENDENT EXPRESSION OF IAP GENES PROTECTS ENDOTHELIAL-CELLS FROM TNFA-INDUCED APOPTOSIS

      Blood
    95. HOLZMULLER H; MECHTCHERIAKOVA D; HOFERWARBINEK R; BINDER BR; HOFER E
      A TRANSCRIPTIONAL REPRESSOR OF THE TISSUE FACTOR GENE

      Blood
    96. BOHM T; GEIGER M; BINDER BR
      ISOLATION AND CHARACTERIZATION OF TISSUE-TYPE PLASMINOGEN ACTIVATOR-BINDING PROTEOGLYCANS FROM HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS

      Arteriosclerosis, thrombosis, and vascular biology
    97. ZHANG WJ; HUFNAGL P; WOJTA J; BINDER BR
      EFFECT OF ASTRAGALOSIDE-IV ON COUNTERACTING ENDOTOXIN-STIMULATED INDUCTION OF E-SELECTIN EXPRESSION AND MONOCYTES ADHESION IN CULTURED HUMAN ENDOTHELIAL-CELLS

      Molecular biology of the cell
    98. ZHANG WJ; HUFNAGL P; WOJTA J; BINDER BR
      MECHANISM OF THE ACTION OF ASTRAGALOSIDE-IV - INHIBITION OF ENDOTOXINEFFECTS THROUGH INDUCTION OF I-KAPPA-B-ALPHA SYNTHESIS

      Molecular biology of the cell
    99. ADDOBOADU K; WOJTA J; CHRIST G; HUFNAGL P; PEHAMBERGER H; BINDER BR
      AZELAIC ACID DECREASES THE FIBRINOLYTIC POTENTIAL OF CULTURED HUMAN-MELANOMA CELLS IN-VITRO

      Cancer letters
    100. HOFBAUER R; BAGHESTANIAN M; KRESS HG; WOJTA J; BINDER BR; GHANNADAN M; MULLER MR; MEHRABI MR; LECHNER K; VALENT P
      VASCULAR CELLS INDUCE MIGRATION OF HUMAN MAST-CELLS - ROLE OF MAST-CELL GROWTH-FACTOR (MGF)

      Experimental hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 03:11:02